documents: FDA-2002-N-0279-0024
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2002-N-0279-0024 | FDA | FDA-2002-N-0279 | Tab 14 - [Reference (Congressional Budget Office "How Increased Competition from Generic Drugs has Affected Prices and Returns in the Pharmaceutical Industry" (July 1998))] - Background Material | Supporting & Related Material | Reference (external attachments) | 2011-11-17T05:00:00Z | 2011 | 11 | 2011-11-17T21:14:20Z | 0 | 0 | 090000648049e6c9 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref